Skip to main content

and
  1. Article

    Open Access

    Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial

    Patients with cancer are at high risk of severe coronavirus disease 2019 (COVID-19), with high morbidity and mortality. Furthermore, impaired humoral response renders severe acute respiratory syndrome coronavi...

    Claudia M. Denkinger, Maike Janssen, Ulrike Schäkel, Julia Gall in Nature Cancer (2023)